Here's Why Investors Should Retain ResMed (RMD) Stock for Now
https://www.zacks.com/stock/news/2228766/here-s-why-investors-should-retain-resmed-rmd-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2228766
Feb 20, 2024 - Investors are optimistic about ResMed's (RMD) increased adoption of AirSense10 and AirSense11 devices.
0
Illumina (ILMN) Rides on NGS Portfolio Expansion Amid Macro Woe
https://www.zacks.com/stock/news/2228631/illumina-ilmn-rides-on-ngs-portfolio-expansion-amid-macro-woe?cid=CS-ZC-FT-analyst_blog|zer_report_update-2228631
Feb 20, 2024 - In reproductive health, Illumina (ILMN) primarily focuses on driving noninvasive prenatal testing (NIPT) adoption globally.
0
AMN Healthcare (AMN) Q4 Earnings and Revenues Beat Estimates
https://www.zacks.com/stock/news/2227450/amn-healthcare-amn-q4-earnings-and-revenues-beat-estimates?cid=CS-ZC-FT-analyst_blog|earnings_article-2227450
Feb 16, 2024 - AMN Healthcare's (AMN) dismal results in the majority of its segments led to a soft overall fourth-quarter performance.
0
ResMed (RMD) to Treat Sleep Apnea With New AirCurve 11 (Revised)
https://www.zacks.com/stock/news/2227458/resmed-rmd-to-treat-sleep-apnea-with-new-aircurve-11-revised?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2227458
Feb 16, 2024 - ResMed's (RMD) new AirCurve11 series incorporates MyAir and AirView digital health apps to provide maximum comfort and support during therapy.
0
Here's Why You Should Retain Insulet (PODD) Stock for Now
https://www.zacks.com/stock/news/2227404/here-s-why-you-should-retain-insulet-podd-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2227404
Feb 16, 2024 - The huge success of Omnipod 5 boosts investors' confidence in Insulet (PODD).
0
Here's Why You Should Retain IDEXX (IDXX) Stock for Now
https://www.zacks.com/stock/news/2227054/here-s-why-you-should-retain-idexx-idxx-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2227054
Feb 15, 2024 - Investors are optimistic about IDEXX (IDXX) growth in CAG business and strong global performance
0
Here's Why You Should Retain CVS Health (CVS) Stock for Now
https://www.zacks.com/stock/news/2226281/here-s-why-you-should-retain-cvs-health-cvs-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2226281
Feb 14, 2024 - Investors are optimistic about CVS Health (CVS) on its strong segmental performance and impressive restructuring plan.
0
Jobless Claims & Productivity Leap Higher; CAH, IP, HON Report
https://www.zacks.com/stock/news/2219629/jobless-claims-productivity-leap-higher-cah-ip-hon-report?cid=CS-ZC-FT-ahead_of_wall_street-2219629
Feb 01, 2024 - Once the market closes, we'll await earnings reports from three of the Magnificent 7 stocks: Apple, Amazon and Meta.
0
Cardinal Health (CAH) Beats on Q2 Earnings, Ups '24 EPS View
https://www.zacks.com/stock/news/2219544/cardinal-health-cah-beats-on-q2-earnings-ups-24-eps-view?cid=CS-ZC-FT-analyst_blog|earnings_article-2219544
Feb 01, 2024 - Cardinal Health's (CAH) second-quarter fiscal 2024 results benefit from the Pharmaceutical segment's solid performance.
0
Medical Device Stocks' Earnings on Feb 1: RVTY, CAH & More
https://www.zacks.com/stock/news/2218722/medical-device-stocks-earnings-on-feb-1-rvty-cah-more?cid=CS-ZC-FT-analyst_blog|earnings_preview_-_esp-2218722
Jan 31, 2024 - Medical Device companies' quarterly results are likely to reflect strength in customer demand. Let's see how CAH, RVTY, CNMD, SRDX and BDX are placed ahead of their earnings releases.
0